Synonyms: Compound S-D1 [WO2021155225A1] | FHD609
Compound class:
Synthetic organic
Comment: FHD-609 is a PROTAC degrader of bromodomain-containing protein 9 (BRD9), that was designed as a treatment for synovial sarcoma and SMARCB1-loss tumours. It is one of the compounds claimed in Foghorn Therapeutics' patent WO2021155225A1 [1]. FHD-609 is suitable for intravenous delivery.
|
|
References |
1. Ruppel SK, Yang Z, Lowe JT, Voigt JH. (2021)
Compounds and uses thereof. Patent number: WO2021155225A1. Assignee: Foghorn Therapeutics Inc.. Priority date: 29/01/2021. Publication date: 05/08/2021. |